Overview
Endotoxemia is the presence of bacterial endotoxin (lipopolysaccharide, LPS) in the bloodstream. Metabolic endotoxemia — chronic, low-grade LPS translocation from the gut — is a central mechanism linking dysbiosis to systemic disease across dozens of conditions in this wiki. It is the molecular bridge between gut barrier failure and systemic inflammation.
Mechanism
- Gut barrier disruption: Loss of tight junction integrity (ZO-1, occludin, claudin) allows LPS from Gram-negative bacteria to translocate across the intestinal epithelium into the portal circulation.
- TLR4 activation: LPS binds TLR4 on macrophages, dendritic cells, and hepatocytes, activating nf kappa b signaling.
- Cytokine cascade: NF-kB drives production of IL-6, TNF-alpha, IL-1beta — the same pro-inflammatory cytokines elevated across virtually every disease signature in this wiki.
- Systemic consequences: Chronic low-grade endotoxemia drives insulin resistance, endothelial dysfunction, neuroinflammation, and hepatic inflammation.
Metal-Microbiome Connection
Heavy metals drive endotoxemia through a two-hit mechanism:
- Hit 1: Metals (cadmium, lead, arsenic) damage tight junctions directly, increasing paracellular permeability [1].
- Hit 2: Metals selectively enrich LPS-rich Gram-negative Enterobacteriaceae while depleting barrier-protective SCFA producers (faecalibacterium prausnitzii, roseburia), increasing the luminal LPS load available for translocation.
The result: more LPS in the lumen AND a leakier barrier = amplified endotoxemia.
Conditions Associated
Metabolic endotoxemia is documented across:
- Cardiovascular disease: LPS drives endothelial dysfunction and atherosclerosis [2].
- Type 2 diabetes: Metabolic endotoxemia → insulin resistance via TLR4/NF-kB [3].
- CKD: Uremic toxins compound LPS-driven inflammation [4] [5] [6].
- Erectile dysfunction: Endotoxemia → endothelial dysfunction → impaired NO-dependent erection [7] [8].
- Neurodegeneration: LPS crosses the blood-brain barrier and activates microglia, driving neuroinflammation.
- Obesity: High-fat diet increases Gram-negative bacteria and gut permeability simultaneously.
Cross-References
- lipopolysaccharide — the endotoxin molecule
- intestinal permeability — barrier failure enabling translocation
- inflammation — downstream systemic consequence
- nf kappa b — signaling pathway activated by LPS/TLR4
- interleukin 6 — key cytokine in endotoxemia-driven inflammation
- dysbiosis — microbial imbalance increasing luminal LPS
- short chain fatty acids — butyrate maintains barrier integrity; depletion enables endotoxemia